Anson Funds Management LP Cel Sci Corp Transaction History

Anson Funds Management LP

  • $839 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018
SELL
$0.83 - $4.16 $279,295 - $1.4 Million
-336,500 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$0.92 - $3.5 $309,580 - $1.18 Million
336,500 New
336,500 $310,000
Q1 2018

May 15, 2018
SELL
$1.38 - $2.33 $363,158 - $613,158
-263,158 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$1.63 - $2.0 $428,947 - $526,316
263,158
263,158 $423,000

Others Institutions Holding CVM

# of Institutions
71
Shares Held
6M
Call Options Held
27.1K
Put Options Held
150K
View Full List

About CEL SCI CORP

CVM Quotes by TradingView
  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $24.3M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Anson Funds Management LP Portfolio

Follow Anson Funds Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anson Funds Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Anson Funds Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email